(PRWEB) May 01, 2011
ZEUS Scientific announces it has received clearance from the U.S. Food and Drug Administration (FDA) to market the ZEUS ELISA HSV gG-1 IgG Test System (product number 9Z9761G). This new Test System is intended for the qualitative detection of type specific IgG class antibodies to Herpes Simplex Virus 1 (HSV-1) in human sera. The test is intended for testing sexually active individuals or pregnant women for aiding in the presumptive diagnosis of HSV-1 infection.
Many ZEUS ELISA Test Systems use a common procedure and share several common reagents, making automation simple and efficient. This allows laboratories to run multiple tests on the same plate, at the same time maximizing ELISA run efficiency and minimizing workflow. In addition, ZEUS ELISA Test Systems include patented SAVe™ Diluent, a sample addition verification system designed to clearly identify patient sera is added to each and every well.
In conjunction with the AtheNA Multi-Lyte® HSV 1&2 IgG Plus Test System (product number A97101G), ZEUS Scientific now offers the clinical market multiple testing solutions for the qualitative detection of type specific IgG class antibodies to Herpes Simplex Virus 1 (HSV-1) in human sera. In addition, ZEUS Scientific anticipates the clearance of the ZEUS ELISA HSV gG-2 IgG Test System, providing the laboratory complete testing solutions for type specific HSV IgG testing, in ELISA and multiplex formats.
Both the ZEUS ELISA HSV gG-1 IgG Test System and the AtheNA Multi-Lyte® HSV 1&2 IgG Plus Test System are available for sale through the global ZEUS Scientific distribution network. Please visit http://www.zeusscientific.com to locate your local distributor.